ApprovalTrail

Drug · DIN 00103624 · Veterinary

TYLAN 10

Authorized, but not sold for a year or more

Authorized, but the company reports it has not been sold in Canada for at least 12 months.

Status Dormant since July 23, 2018; first marketed December 31, 1958.
Drug Identification Number (DIN)
00103624
Company (DIN owner)
Elanco Canada LimitedGuelph, Ontario, Canada
Schedule
Prescription
Dosage form
Drug Premix
Route
Oral
Class
Veterinary
Record last updated
March 22, 2025

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
TYLOSIN (TYLOSIN PHOSPHATE)22 GKg

Notices of Compliance

Health Canada approvals that name this DIN.

  • March 1, 2018: NOC 20538New Drug Submission (NDS) · Merger - buyout
  • February 15, 2018: NOC 20490Supplement to a New Drug Submission (SNDS) · Removal of growth promotion claim, change to prescription status, labelling updates
  • August 8, 2012: NOC 13544Supplement to a New Drug Submission (SNDS) · Manufacturing Changes
  • November 2, 2009: NOC 10737Supplement to a New Drug Submission (SNDS) · Additional swine indication
  • October 12, 2007: NOC 9080Supplement to a New Drug Submission (SNDS) · New indications: (1) as an aid in the treatment of necrotic enteritis caused by clostridium perfringens in broiler chickens (2) as an aid in the treatment of procine proliferative enteropathy (ppe) or ileitis associated with lawsonia intracellularis when used following treatment with elanco tylan soluble
  • September 19, 2001: NOC 6190Supplement to a New Drug Submission (SNDS) · To provide for the use of this product in a thixotrope liquid supplement manufactured by hcs, nutrena feeds, cargill ltd. and by promolas, div. of tate & lyle n.a. sugars ltd.
  • December 23, 1997: NOC 6888Supplement to a New Drug Submission (SNDS) · Additional claim
  • December 23, 1997: NOC 6910Supplement to a New Drug Submission (SNDS) · To provide for a zero-day withdrawal period